NewsFDA Cosmetics Inspection: What the Draft Guidance on Records Access Means for Manufacturers FDA Inspections Team / February 22, 2026
InspectionsCommon Deficiencies Cited in FDA Cosmetic Inspections and How to Avoid Enforcement Actions FDA Inspections Team / February 22, 2026
InspectionsFSMA Risk-Based Inspection Frequency: What Food Processors Need to Know in 2026 FDA Inspections Team / February 22, 2026
Warning LettersCosmetic Labeling Violations from Recent FDA Inspections and Warning Letters (2025-2026) FDA Inspections Team / February 22, 2026
InspectionsHow to Prepare for FDA Data Integrity Inspections in Drug Manufacturing in 2026 FDA Inspections Team / February 22, 2026
InspectionsFDA Food Facility Inspection Observations: Top Preventive Control Violations from Recent Reports FDA Inspections Team / February 22, 2026
Warning LettersPharmaceutical QA: Responding to FDA 483 Observations on Sterility and Potency Controls FDA Inspections Team / February 22, 2026
InspectionsHow New FDA Drug Facility Inspection Findings Are Impacting Pharma Supply Chain Compliance FDA Inspections Team / February 22, 2026
InspectionsPost-Inspection Action Plans After an FDA Export Detention or Import Alert for Food Imports FDA Inspections Team / February 22, 2026
Warning LettersWhat FDA Pharmaceutical CGMP Inspection Trends Reveal from the Latest Warning Letters (2025-2026) FDA Inspections Team / February 22, 2026
